Casma Therapeutics
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Technology Sq Ste 201, Cambridge, Ma...Phone Number
(857) 777-4990Website
www.casmatx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Casma Therapeutics
Casma Therapeutics is headquartered out of Cambridge, Massachusetts and was founded in 2018. Harnessing the natural cellular process of autophagy to open vast new target areas for drug discovery and development.Explore more
Casma Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Casma Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Casma Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Casma Therapeutics
Earning: See what the market has to say on Casma Therapeutics recently announced quarterly report
Check if Casma Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Casma Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Casma Therapeutics launches new products
Check out if Casma Therapeutics is spiking on competitors!
Click to see if Casma Therapeutics had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Casma Therapeutics
Compare insights from companies similar to Casma Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Casma Therapeutics
<$5M
11-50
Private
$46M
2018
Herbert VirginFounder & Chief Medical Officer and Head, Altos Institute of Medicine
Company Profile Activity
Activity Insights
Casma Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Casma Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Casma Therapeutics.
Casma Therapeutics financials insights
Gather financial insights about Casma Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series C
$46M
Casma Therapeutics Tech Stack
A closer look at the technologies used by Casma Therapeutics
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Promotion
Executive Move
Executive Move
Board of Directors
Casma Therapeutics News & Media
Casma Therapeutics Raises $46.0 M in Series C Funding
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Casma closes a $46 M Series C financing with 6 new investors plus 100% commitment from existing investors.Casma Therapeutics to Present at the UBS Virtual Biotechnology Private Company Symposium
CAMBRIDGE, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced that Keith Dionne, Ph.D., Chief Executive Officer of Casma, will participate in the upcoming virtual UBS Virtual Biotechnology Private Company Symposium being held on September 22-23, 2021.Casma Therapeutics Announces Addition of Sharon Tooze, Ph.D. to Scientific Advisory Board
CAMBRIDGE, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced the appointment of Sharon Tooze, Ph.D. to its scientific advisory board (SAB).Casma Therapeutics to Present at Oppenheimer Rare & Orphan Disease Summit
CAMBRIDGE, Mass., May 14, 2021 (GLOBE NEWSWIRE) -- Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced that Chief Executive Officer, Keith Dionne, Ph.D., will present a company overview at the upcoming Oppenheimer Rare & Orphan Disease Summit on Friday, May 21, 2021 at 8:15 a.m. ET.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Casma Therapeutics
Sign Up For FreeTo access detailed company insights
Casma Therapeutics is headquartered out of Cambridge, Massachusetts and was founded in 2018. Harnessing the natural cellular process of autophagy to open vast new target areas for drug discovery and development.... Read More
